Cargando…

Natalizumab-induced thrombocytopenia: A case report

Detalles Bibliográficos
Autores principales:	Azimi, Amirreza, Abna, Zohreh, Ghadiri, Fereshteh, Mehrabi, Farzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527860/ https://www.ncbi.nlm.nih.gov/pubmed/38011417 http://dx.doi.org/10.18502/cjn.v21i1.9363

Ejemplares similares

Natalizumab-induced pneumonitis
por: Kaninia, Stefania, et al.
Publicado: (2021)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Risperidone-induced thrombocytopenia in a case of psychosis and neuroendocrine tumor: A case report
por: Saxena, Sachin Kumar, et al.
Publicado: (2021)

Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
por: Sood, Arjun B., et al.
Publicado: (2016)

Vaccine-Induced Immune Thrombotic Thrombocytopenia: First Case Report in South Korea
por: Kim, Min Kyung, et al.
Publicado: (2021)

Chlorella-induced thrombocytopenia
por: Yavasoglu, Irfan, et al.
Publicado: (2018)

“A new case of myasthenia gravis following COVID-19 Vaccination”
por: Abna, Zohreh, et al.
Publicado: (2022)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Is Monkeypox a Concern in Multiple Sclerosis Patients? A Letter to Editor
por: Asadollahzadeh, Elnaz, et al.
Publicado: (2022)

The unexpected finding of a hemangioblastoma on the cerebellum of a patient undergoing treatment with natalizumab for multiple sclerosis
por: Fragoso, Yara Dadalti, et al.
Publicado: (2017)

Natalizumab-Induced Pustular Psoriasis of Palms and Soles
por: Ozarslan, Bengisu, et al.
Publicado: (2022)

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Heparin induced thrombocytopenia-type 2
por: Majeed, Tanveer A.
Publicado: (2010)

Drug-induced immune-mediated thrombocytopenia
por: Singh, Harpreet, et al.
Publicado: (2020)

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Re: Heparin-induced thrombocytopenia – Type 2
por: Yagnik, Vipul D.
Publicado: (2011)

Heparin-induced thrombocytopenia in a patient with colon cancer
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Heparin-induced thrombocytopenia in a patient with colon cancer
por: Koul, Ajaz Nabi, et al.
Publicado: (2013)

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial
por: Shafaei, Maryam, et al.
Publicado: (2022)

Comparison of nadir serum concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients
por: Tanaka, Masami, et al.
Publicado: (2016)

How to improve the management of a patient with heparin-induced thrombocytopenia?
por: Undas, Anetta
Publicado: (2019)

Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature
por: Gardellini, Angelo, et al.
Publicado: (2021)

Thrombocytopenia due to rifampicin
por: Dixit, Ramakant, et al.
Publicado: (2012)

Thrombocytopenia due to rifampicin
por: Gupta, Prahlad Rai
Publicado: (2012)

Dengue, HIV and thrombocytopenia
por: Garg, Pankaj, et al.
Publicado: (2008)

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: May, Jori E., et al.
Publicado: (2020)

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
por: Hu, Zhiliang, et al.
Publicado: (2020)

Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: Riker, Richard R., et al.
Publicado: (2020)

Organ transplantation from deceased donors with vaccine‐induced thrombosis and thrombocytopenia
por: Greenhall, George H. B., et al.
Publicado: (2021)

Perceval Induces Thrombocytopenia: Yes, of Course, but can we Change the Paradigm?
por: Condello, Ignazio, et al.
Publicado: (2021)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
por: Erçalışkan, Abdülkadir, et al.
Publicado: (2022)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

Anaesthetic management of a parturient with severe idiopathic thrombocytopenia and neonatal thrombocytopenia posted for elective caesarean section
por: Puthenveettil, Nitu, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia presenting as a mimic of heparin-induced thrombocytopenia in a hemodialysis patient receiving ChAdOx1 nCoV-19 vaccine
por: Lin, Yi-Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_daf2h1dg67omjmu355blo7pc5c